| Line item | 2025-12-31 FY | 2024-12-31 FY | 2023-12-31 FY | 2022-12-31 FY | 2021-12-31 FY |
|---|---|---|---|---|---|
| Revenue | $20.60M | $3.75M | $140.14M | $5.09M | $13.16M |
| Cost of Revenue | – | – | – | – | – |
| Gross Profit | – | – | – | – | – |
| Operating Expenses | $36.67M | $40.86M | $67.47M | $90.85M | $74.00M |
| R&D | $22.28M | $26.41M | $30.93M | $27.26M | $23.77M |
| SG&A | $14.39M | $14.46M | $20.92M | $62.96M | $49.92M |
| Operating Income | -$16.07M | -$37.12M | $72.67M | -$85.76M | -$60.84M |
| Interest Expense | – | – | $3.13M | $5.20M | $2.66M |
| Tax Expense | $0.00 | $151.00K | $138.00K | -$4.70M | -$3.09M |
| Net Income | -$8.61M | -$21.29M | $67.04M | -$62.81M | -$32.87M |
| EPS (basic) | -0.1700 | -0.4400 | 1.4000 | -1.4700 | -1.2500 |
| EPS (diluted) | -0.1700 | -0.4400 | 1.3900 | -1.4700 | -1.2500 |
| Shares (diluted) | $49.93M | $48.51M | $48.39M | $42.61M | $26.38M |